Price: quote on request. Your total cost is quoted in writing per case.
We reply within one business dayGet my quote

Small cell lung cancer (SCLC): US-approved treatments and how Gulf families can access them

Creator: Reserve Meds
Published: 2026-10-17

A plain guide for families in the Gulf, checked against US FDA labels, Gulf drug registers and published medical research.

Reviewed by the Reserve Meds clinical operations team on 17 October 2026.

Small cell lung cancer: the short answer

For small cell lung cancer, the US FDA has approved two medicines covered on this page, each for a specific group of patients: Imdelltra and Zepzelca. Imdelltra is already on at least one Gulf list, so start by asking your hospital about local supply. Where a medicine is not registered in your country, the treating hospital can ask the national regulator for permission to import it for one named patient. Reserve Meds is a digital health company that helps families and hospitals with that process. We do not diagnose or prescribe.

US FDA-approved medicines on this page: Imdelltra and Zepzelca.
Gulf registration (checked 17 October 2026): see each medicine below.
Legal route: Local supply where listed; otherwise a named-patient import request filed by the treating hospital.
Price: Quote on request.

What is small cell lung cancer?

Small cell lung cancer is a fast-growing cancer that forms in the tissues of the lung. It is less common than non-small cell lung cancer. Smoking is the major risk factor. Signs include coughing and shortness of breath.^[1]

After diagnosis, doctors check whether the cancer has spread within the chest or to other parts of the body. The newer US-approved options on this page, the T-cell engager Imdelltra and the medicine Zepzelca, are for cancer that has grown on or after platinum-based chemotherapy, or, for Zepzelca, as maintenance after first-line treatment.^{[1, 2, 3]}

Small cell lung cancer in the Gulf

This is one of the few hubs where a newer medicine is already on Gulf lists. When we checked on 17 October 2026, tarlatamab was listed in the SFDA drugs list (under the name IMDYLLTRA) and in the Abu Dhabi Department of Health drug code list. So for families in Saudi Arabia and Abu Dhabi, the first step is to ask the treating oncology center about local supply.^{[4, 5]}

We did not check Zepzelca in those registers, and we do not have public register data for Kuwait, Qatar or Oman. If a medicine is not available locally, the hospital can ask its regulator about a named-patient import.^{[6, 7]}

US FDA-approved medicines for small cell lung cancer

Each medicine below is approved in the US for a specific group of patients. The wording follows the current US label. Your specialist decides whether any of them is right for the patient.

Imdelltra (tarlatamab-dlle)
FDA-approved for adults with extensive-stage small cell lung cancer that has grown on or after platinum-based chemotherapy. It is given as an intravenous infusion in hospital, with step-up dosing to lower the risk of cytokine release syndrome.^{[8, 2]}
US FDA approval: 16 May 2024. Gulf registers: Saudi Arabia: listed in the SFDA drugs list (as IMDYLLTRA). Abu Dhabi: listed in the Abu Dhabi DoH drug code list. Bahrain: not found in the NHRA registered medicines list. Checked 17 October 2026. Kuwait, Qatar and Oman: no public register checked.^{[4, 5, 9]}
Country guides: Saudi Arabia, UAE, Qatar, Bahrain, Egypt, Iraq, India, Pakistan
Zepzelca (lurbinectedin)
FDA-approved for adults with extensive-stage small cell lung cancer as maintenance treatment with atezolizumab after first-line induction therapy, and adults with metastatic small cell lung cancer that has grown on or after platinum-based chemotherapy (accelerated approval for this second use).^[3]
Current US label version: 27 February 2026. Gulf registers: Not part of our 17 October 2026 Gulf register check. We confirm the status for your country when you ask.

How families in the Gulf can access these medicines

If the medicine is listed in your country. Ask your specialist and the hospital pharmacy about local supply first. A listing does not mean every hospital stocks the medicine, but it is usually the fastest route, and you may not need us.

If it is not registered. The usual legal route is a named-patient request: the treating hospital, on your specialist's written request, asks the national regulator for permission to import the medicine for one patient, using the US FDA approval as the reference. In Saudi Arabia the SFDA Special Access Program guidance covers these requests; in Bahrain, NHRA Circular 41 of 2020 sets the procedure. Other Gulf countries have their own procedures, which the hospital pharmacy confirms.^{[6, 7]} Once approval is in place, Reserve Meds arranges supply through a US-licensed pharmaceutical wholesale partner to the hospital pharmacy.

Who does what

Your treating specialist decides whether a medicine is right for the patient and writes the letter.
The hospital checks local supply, files any import request, and gives the treatment safely.
The national regulator decides whether to approve the import of a medicine that is not registered.
The manufacturer decides where its medicine can be supplied, especially for cell and gene therapies.
Reserve Meds helps organize records, coordinates US supply through our wholesale partner, shipping and updates to your family. We do not give medical advice.

Documents you will usually need

A letter from the treating specialist with the diagnosis, past treatments and why this medicine is being considered
Reports that confirm the diagnosis, such as genetic, pathology or laboratory results, translated into English where needed
Recent clinic notes and a list of current medicines
For a hospital import request: the prescription, the hospital's request form and the written consent of the patient or guardian
Proof of the US FDA approval and the US prescribing information (we can supply these)

We give you a written timeline estimate once we see the hospital file. The regulator, the treatment center and the manufacturer set their own timelines.

What treatment costs

Quote on request. Your total cost depends on the medicine, the dose, shipping, import steps and coordination. Your coordination fee is quoted in writing for your case before you commit. No hidden charges.

How Reserve Meds helps

Reserve Meds is a digital health company. Medicines are supplied through a US-licensed pharmaceutical wholesale partner. We help your doctor and hospital prepare the file, arrange US supply and temperature-controlled shipping once approval is in place, and keep your family updated. We coordinate access to FDA-approved medicines only. Investigational medicines are only available through a manufacturer's expanded-access program requested by the treating physician; we can explain that route, but we do not supply them.

Ask us about treatment for small cell lung cancer

Tell us the medicine, the country, and how to reach you. We reply within one business day. On WhatsApp we usually reply the same day.

Message us on WhatsApp Already have a case? Sign in

Your coordination fee is quoted in writing for your case before you commit. No hidden charges.

Frequently asked questions

Is there an FDA-approved treatment for small cell lung cancer?

Yes. The medicines on this page have US FDA approval for specific groups of patients: Imdelltra and Zepzelca. The exact conditions are in each US label and are summarized above. Your specialist decides whether any of them fits.

Is Imdelltra available in Saudi Arabia or the UAE?

Saudi Arabia: listed in the SFDA drugs list (as IMDYLLTRA). Abu Dhabi: listed in the Abu Dhabi DoH drug code list. Bahrain: not found in the NHRA registered medicines list. Checked 17 October 2026. Kuwait, Qatar and Oman: no public register checked. A listing in Abu Dhabi does not show federal UAE status, which we could not verify.

How can a family in the Gulf get Imdelltra?

Ask the treating hospital about local supply first. If it is not available, the hospital can file a named-patient import request with the national regulator on your specialist's written request. Once approved, we arrange US supply to the hospital pharmacy.

How much does treatment cost?

Quote on request. Your total cost, including the medicine, shipping, import steps and coordination, is quoted in writing for your case before you commit. No hidden charges.

Does Reserve Meds diagnose or prescribe?

No. Reserve Meds is a digital health company. Medicines are supplied through a US-licensed pharmaceutical wholesale partner. We do not diagnose, prescribe or decide what a regulator approves. Your specialist and hospital make the medical decisions.

Is Imdelltra available in Saudi Arabia?

On 17 October 2026 tarlatamab was listed in the SFDA drugs list as IMDYLLTRA. Listing does not mean every hospital stocks it, so ask the treating oncology center about supply first.

Sources for the last answer: ^[4]

Sources

Checked on 17 October 2026. Labels, registers and regulator rules change. Your hospital pharmacy confirms the current position before filing.

This page is general health information, not medical advice. It does not replace a consultation with your doctor.